Following the exodus at Immunocore, Eliot Forster takes the reins at F-star — how long before the crossover and an IPO?
LONDON — Over the past 12 years, F-star has built up a rep for antibody design work that’s garnered the avid attention of a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
